tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
US Market

Sarepta Therapeutics (SRPT) Income Statement

Compare
3,145 Followers

Sarepta Therapeutics Income Statement

Last quarter (Q3 2024), Sarepta Therapeutics's total revenue was $467.17M, an increase of 40.79% from the same quarter last year. In Q3, Sarepta Therapeutics's net income was $33.61M. See Sarepta Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.24B$ 933.01M$ 701.89M$ 540.10M$ 380.83M
Gross Profit
$ 1.09B$ 793.02M$ 604.84M$ 476.72M$ 324.25M
Operating Expenses
$ 1.36B$ 1.33B$ 1.05B$ 1.04B$ 846.57M
Depreciation and Amortization
$ 58.89M$ 54.60M$ 49.34M$ 39.74M$ 30.55M
EBITDA
$ -439.20M$ -582.12M$ -306.08M$ -453.38M$ -652.66M
Operating Income
$ -267.82M$ -536.20M$ -449.71M$ -564.16M$ -522.32M
Other Income/Expenses
$ -252.27M$ -153.76M$ 40.76M$ 11.10M$ -8.32M
Pretax Income
$ -520.10M$ -689.96M$ -418.95M$ -553.07M$ -713.88M
Net Income
$ -535.98M$ -703.49M$ -418.78M$ -554.13M$ -715.08M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.80$ -8.03$ -5.15$ -7.11$ -9.71
Diluted EPS
$ -5.80$ -8.03$ -5.15$ -7.11$ -9.71
Weighted Average Shares Outstanding
92.40M 87.56M 81.26M 77.96M 73.61M
Weighted Average Shares Outstanding (Diluted)
92.40M 87.56M 81.26M 77.96M 73.61M
Currency in USD

Sarepta Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis